LncRNAH19 acts as a ceRNA of let-7 g to facilitate endothelial-to-mesenchymal transition in hypoxic pulmonary hypertension via regulating TGF-β signalling pathway

Xin Yu,Jiabing Huang,Xu Liu,Juan Li,Miao Yu,Minghui Li,Yuliang Xie,Ye Li,Junyu Qiu,Zhou Xu,Tiantian Zhu,Weifang Zhang
DOI: https://doi.org/10.1186/s12931-024-02895-y
IF: 5.8
2024-07-13
Respiratory Research
Abstract:Hypoxic pulmonary hypertension (HPH) is a challenging lung arterial disorder with remarkably high incidence and mortality rates, and the efficiency of current HPH treatment strategies is unsatisfactory. Endothelial-to-mesenchymal transition (EndMT) in the pulmonary artery plays a crucial role in HPH. Previous studies have shown that lncRNA-H19 (H19) is involved in many cardiovascular diseases by regulating cell proliferation and differentiation but the role of H19 in EndMT in HPH has not been defined.
respiratory system
What problem does this paper attempt to address?